122 related articles for article (PubMed ID: 21295472)
21. A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity.
Guglielmo S; Bertinaria M; Rolando B; Crosetti M; Fruttero R; Yardley V; Croft SL; Gasco A
Eur J Med Chem; 2009 Dec; 44(12):5071-9. PubMed ID: 19811859
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and molecular docking studies of 1-phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agents.
Pandey VP; Bisht SS; Mishra M; Kumar A; Siddiqi MI; Verma A; Mittal M; Sane SA; Gupta S; Tripathi RP
Eur J Med Chem; 2010 Jun; 45(6):2381-8. PubMed ID: 20199824
[TBL] [Abstract][Full Text] [Related]
23. Constituents of Tinospora sinensis and their antileishmanial activity against Leishmania donovani.
Maurya R; Gupta P; Chand K; Kumar M; Dixit P; Singh N; Dube A
Nat Prod Res; 2009; 23(12):1134-43. PubMed ID: 19662579
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of original amidoximes as antileishmanial agents.
Bouhlel A; Curti C; Dumètre A; Laget M; Crozet MD; Azas N; Vanelle P
Bioorg Med Chem; 2010 Oct; 18(20):7310-20. PubMed ID: 20833057
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.
Esteves MA; Fragiadaki I; Lopes R; Scoulica E; Cruz ME
Bioorg Med Chem; 2010 Jan; 18(1):274-81. PubMed ID: 19926293
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives.
Mäntylä A; Rautio J; Nevalainen T; Vepsälainen J; Juvonen R; Kendrick H; Garnier T; Croft SL; Järvinen T
Bioorg Med Chem; 2004 Jul; 12(13):3497-502. PubMed ID: 15186834
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
[TBL] [Abstract][Full Text] [Related]
29. Parallel synthesis and antileishmanial activity of ether-linked phospholipids.
Coghi P; Vaiana N; Pezzano MG; Rizzi L; Kaiser M; Brun R; Romeo S
Bioorg Med Chem Lett; 2008 Aug; 18(16):4658-60. PubMed ID: 18644723
[TBL] [Abstract][Full Text] [Related]
30. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
[TBL] [Abstract][Full Text] [Related]
31. Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro.
Torrence PF; Fan X; Zhang X; Loiseau PM
Bioorg Med Chem Lett; 2006 Oct; 16(19):5047-51. PubMed ID: 16879965
[TBL] [Abstract][Full Text] [Related]
32. The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro.
Heurtault B; Legrand P; Mosqueira V; Devissaguet JP; Barratt G; Bories C
Ann Trop Med Parasitol; 2001 Jul; 95(5):529-33. PubMed ID: 11487374
[No Abstract] [Full Text] [Related]
33. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
34. In pursuit of natural product leads: synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and its analogues: discovery of N-(2-benzoxazol-2-ylphenyl)benzamides as novel antileishmanial chemotypes.
Tipparaju SK; Joyasawal S; Pieroni M; Kaiser M; Brun R; Kozikowski AP
J Med Chem; 2008 Dec; 51(23):7344-7. PubMed ID: 18989953
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and in vitro antiprotozoal activity of benzimidazole-pentamidine hybrids.
Torres-Gómez H; Hernández-Núñez E; León-Rivera I; Guerrero-Alvarez J; Cedillo-Rivera R; Moo-Puc R; Argotte-Ramos R; Rodríguez-Gutiérrez Mdel C; Chan-Bacab MJ; Navarrete-Vázquez G
Bioorg Med Chem Lett; 2008 Jun; 18(11):3147-51. PubMed ID: 18486471
[TBL] [Abstract][Full Text] [Related]
36. S-Euglobals: biomimetic synthesis, antileishmanial, antimalarial, and antimicrobial activities.
Bharate SB; Khan SI; Tekwani BL; Jacob M; Khan IA; Singh IP
Bioorg Med Chem; 2008 Feb; 16(3):1328-36. PubMed ID: 17976995
[TBL] [Abstract][Full Text] [Related]
37. Redox-active dinitrodiphenylthioethers against Leishmania: synthesis, structure-activity relationships and mechanism of action studies.
Delfín DA; Morgan RE; Zhu X; Werbovetz KA
Bioorg Med Chem; 2009 Jan; 17(2):820-9. PubMed ID: 19058972
[TBL] [Abstract][Full Text] [Related]
38. Identification of the benzodiazepines as a new class of antileishmanial agent.
Clark RL; Carter KC; Mullen AB; Coxon GD; Owusu-Dapaah G; McFarlane E; Duong Thi MD; Grant MH; Tettey JN; Mackay SP
Bioorg Med Chem Lett; 2007 Feb; 17(3):624-7. PubMed ID: 17113290
[TBL] [Abstract][Full Text] [Related]
39. Original quinazoline derivatives displaying antiplasmodial properties.
Kabri Y; Azas N; Dumètre A; Hutter S; Laget M; Verhaeghe P; Gellis A; Vanelle P
Eur J Med Chem; 2010 Feb; 45(2):616-22. PubMed ID: 19926173
[TBL] [Abstract][Full Text] [Related]
40. Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.
Bharate SB; Khan SI; Yunus NA; Chauthe SK; Jacob MR; Tekwani BL; Khan IA; Singh IP
Bioorg Med Chem; 2007 Jan; 15(1):87-96. PubMed ID: 17070063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
